Stay updated on Azacitidine + Pembrolizumab in AML Clinical Trial

Sign up to get notified when there's something new on the Azacitidine + Pembrolizumab in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine + Pembrolizumab in AML Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    A new Locations section lists Maryland, North Carolina, and South Carolina, replacing the previous individual location entries. The HHS Vulnerability Disclosure link has been removed, and the page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-18T21:09:01.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Added a clarifying note that publications are automatically filled from PubMed and updated the revision to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-27T03:06:19.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    A site-wide government funding status notice has been removed. The core study details and contacts remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-19T22:00:36.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The Study Details page preserves the same core information as before (title, interventions, status, eligibility criteria, locations). Only minor formatting or layout adjustments are evident.
    Difference
    0.4%
    Check dated 2025-10-29T06:25:31.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Added a government funding/operating-status notice and bumped version to v3.2.0, replacing the prior v3.1.0.
    Difference
    2%
    Check dated 2025-10-07T23:09:44.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    Upgrade from v3.0.2 to v3.1.0, updating the page version identifier.
    Difference
    0.1%
    Check dated 2025-09-30T02:39:57.000Z thumbnail image

Stay in the know with updates to Azacitidine + Pembrolizumab in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine + Pembrolizumab in AML Clinical Trial page.